Kanabo Group steadies today — has patient access become the sector's real battleground?

Kanabo Group steadies today — has patient access become the sector's real battleground? →

Highlights Kanabo Group held ground with an access-led model in focus Prescription pathways increasingly shape sector commercial outcomes Listed participants span pharmaceutical, consumer and distribution models Kanabo Group (LSE:KNB) found…